|4May 19, 7:00 AM ET

Michelon Francois Roger 4

4 · ENDRA Life Sciences Inc. · Filed May 19, 2022

Insider Transaction Report

Form 4
Period: 2022-05-17
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-05-17$0.19/sh+5,100$96997,191 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION